ARRDC3 inhibits liver fibrosis and epithelial-to-mesenchymal transition via the ITGB4/PI3K/Akt signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ARRDC3 inhibits liver fibrosis and epithelial-to-mesenchymal transition via the ITGB4/PI3K/Akt signaling pathway

Published:2022-10-12 Issue:2 Volume:45 Page:160-171
ISSN:0892-3973
Container-title:Immunopharmacology and Immunotoxicology
language:en
Short-container-title:Immunopharmacology and Immunotoxicology

Author:

Zhang Bingling¹,Wu Feng²,Li Pingping²,Li Haiding³

Affiliation:

1. Department of Preventive Medicine, Zhuangqiao Branch of Ningbo Ninth Hospital Medical Health Group, Ningbo, Zhejiang, China

2. Jiangbei Center for Disease Control and Prevention, Ningbo, Zhejiang, China

3. Zhuangqiao Branch of Ningbo Ninth Hospital Medical Health Group, Ningbo, Zhejiang, China

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08923973.2022.2128369

Reference40 articles.

1. Hepatitis B Virus: From Diagnosis to Treatment

2. Pathogenesis of Liver Fibrosis

3. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives

4. Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trophoblast fusion in fetal growth restriction is inhibited by CTGF in a cell-cycle-dependent manner;Journal of Molecular Histology;2024-08-10

2. Nrf2/HO‐1, NF‐κB and PI3K/Akt signalling pathways decipher the therapeutic mechanism of pitavastatin in early phase liver fibrosis in rats;Journal of Cellular and Molecular Medicine;2024-01-12

3. Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses;Cell Death & Differentiation;2023-12-14

4. Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses;2023-09-19

5. Biased Quantification of Rat Liver Fibrosis—Meta-Analysis with Practical Recommendations and Clinical Implications;Journal of Clinical Medicine;2023-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3